I was told I'm being overly optimistic. Part of that is to

New Post Public Reply Private Reply Replies (3) Message Board
BooDog
484
I was told I'm being overly optimistic. Part of that is to out post the liars that continuously post bs.

But I'll go on. I consider my dd over the last 6 - 7 years on CTIX/IPIX just as important as the studies themselves by the company. Otherwise I would have moved on long ago.

All trials successful to date.

Lets run prurisol, my scores...
How bout a WHO of much greater than 75%. Possibly 85 - 90%. And we could still be impressed even more. Or not. But I think it moves on favorably.

Brilacidin topical treatments. The brilacidin franchise. What we know is looking pretty solid to move on. brilacidin ABBBSI may be coming back to life in due time. B-OM is the worm on the hook.

Kevetrin oral. Temporarily paused but about half way through toxicology.

The prudence of controlling dilution to move forward under a partnership is just that. Time to see if Leo and Dr. B made the right choices is drawing close.

Now where did I put my crystal ball?

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Inseego Corp to Showcase Innovations at Roth Conference

Updated Category News Views 235

Inseego Corp Highlights Its Participation in Major Conference Inseego Corp. (NASDAQ: INSG), a pioneer in 5G mobile and fixed wireless solutions, is preparing to showcase its latest developments at a prominent industry event. During this conference, Inseego plans to share its vision and growth strategy with investors, emphasizing the importance of its innovative solutions...

Continue Reading
SharpLink Gaming Enhances ETH Treasury Strategy in 2025

Updated Category News Views 255

SharpLink Gaming Reinforces Its Strategic ETH Holdings SharpLink Gaming, Inc. (Nasdaq: SBET), recognized as one of the leading corporate holders of Ether (ETH), has shared its financial outcomes for the recent quarter, specifically ending June 30, 2025. This news outlines SharpLink's transition towards an aggressive ETH treasury management strategy, aiming to not just...

Continue Reading
Exploring High-Yield Stocks with Strong Momentum Potential

Updated Category News Views 188

Dividend Stocks With Momentum: A Rare Combination Dividend stocks often get labeled as the safe, reliable choice for investors, but they can sometimes come off as a bit dull. They are typically associated with stable, mature companies and might lack the exciting growth stories that draw in high-flying investors. Nevertheless, they can play a crucial role in a well-rounded...

Continue Reading
Class Action Alert on Skyworks Solutions: Know Your Rights

Updated Category News Views 115

Understanding the Class Action Suit Against Skyworks Solutions Investors in Skyworks Solutions, Inc. (NASDAQ: SWKS) should be aware of a significant class action lawsuit that has been initiated against the company. Pomerantz LLP has announced this crucial legal development, advocating for those who have suffered losses from their investments in the company. The Nature of...

Continue Reading
Planet Smoothie Joins Fight Against Childhood Cancer

Updated Category News Views 11

Shaking Up September by Fighting Childhood Cancer Here's a refreshing twist on a complex issue: Planet Smoothie's latest campaign against childhood cancer. They're striding alongside Alex's Lemonade Stand Foundation (ALSF) to drum up support and dollars for a cause that touches many of our hearts. With September in full swing, this partnership isn't just about refreshing,...

Continue Reading